American Regent, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 4150 Lyman Drive, Hilliard, Ohio (OH) 43026, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3005761472 · DUNS 606821721
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-07-20
- VAIDrug Quality Assurance2019-03-08
- NAIDrug Quality Assurance2017-08-18
- VAIDrug Quality Assurance2016-12-07
- VAIDrug Quality Assurance2014-04-04
- NAIDrug Quality Assurance2011-09-30
- VAIDrug Quality Assurance2009-01-23
Drugs this plant is listed as making
8 distinct drugs across 16 products name this site in their FDA label.
- Betamethasone Sodium Phosphate and Betamethasone AcetateAmerican Regent, Inc.
- epinephrineAmerican Regent, Inc.
- Ferric CarboxymaltoseAmerican Regent, Inc.
- Ferric Carboxymaltose InjectionAmerican Regent, Inc.
- fomepizoleAmerican Regent, Inc.
- iron sucroseAmerican Regent, Inc.
- tranexamic acidAmerican Regent, Inc.
- VasopressinAmerican Regent, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.